Almagate

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Almagate
Clinical data
AHFS/Drugs.com International Drug Names
Oral
Identifiers
66827-12-1
A02AD03
PubChem CID 71749
ChemSpider 64792 YesY
UNII 568Z59H7ZJ YesY
KEGG D02821 YesY
Chemical data
Formula Al2Mg6(OH)14(CO3)2 · 4 H2O
314.99 g/mol
 YesY (what is this?)  (verify)

Almagate (trade name Almax) is an aluminium- and magnesium-containing antacid. It was first described in 1984.[1][2]

Adverse effects[edit]

Almagate is well tolerated. In a clinical trial, the most common adverse effects were diarrhea and nausea.[3]

References[edit]

  1. ^ Moragues, J. B. (1984). "Characterization of a new crystalline synthetic gastric antacid, almagate" (FREE FULL TEXT). Arzneimittel-Forschung 34 (10A): 1346–1349. ISSN 0004-4172. PMID 6548918.  edit
  2. ^ Beneyto, J. F. B. (1984). "Evaluation of a new antacid, almagate" (FREE FULL TEXT). Arzneimittel-Forschung 34 (10A): 1350–1354. ISSN 0004-4172. PMID 6439224.  edit
  3. ^ Suau, A. D.; Dominguez Martin, A; Ferrando Cucarella, J; Juncosa Iglesias, L; Muñoz Benitez, J; Nieto Calvet, M; Pérez Gieb, J; Pérez Mota, A; Pineda Garcia, A; Rodriguez Sanchez, E (1984). "Treatment of gastric pyrosis with almagate in patients with and without endoscopically demonstrable duodenal ulcer. A multicentre clinical trial" (FREE FULL TEXT). Arzneimittel-Forschung 34 (10A): 1380–1383. ISSN 0004-4172. PMID 6548926.  edit